RxDoctor Payments DataLook up a doctor →

Eric Ponder, PA

Medical · Jacksonville, FLNPI 1447761630

Payments from drug & device makers

$66,853in general payments, 2019–2025

Across 1,005 payments — averaging $66.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$50K
  • Biohaven Pharmaceutical Holding Company Ltd.$2K
  • Jazz Pharmaceuticals Inc.$1K
  • Amgen$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Pfizer$1K
  • plus $10K from 50 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)350$49,500
Biohaven Pharmaceutical Holding Company Ltd.18$2,231
Jazz Pharmaceuticals Inc.50$1,473
Amgen(2 entities)49$1,249
Teva Pharmaceuticals USA, Inc.102$1,187
Pfizer22$1,092
Lilly USA, LLC32$808
Lundbeck LLC35$766
Novartis44$765
Eisai Inc.25$649
Amneal Pharmaceuticals LLC23$607
Neurocrine Biosciences, Inc.28$594
MDD US Operations, LLC10$577
Biogen18$478
Argenx US, Inc.7$347
EMD Serono, Inc.11$329
Acadia Pharmaceuticals Inc14$298
AstraZeneca(2 entities)16$293
UCB, Inc.7$260
Neurelis, Inc.10$222
Otsuka America Pharmaceutical, Inc.10$209
Impel Pharmaceuticals Inc.11$204
Octapharma USA, Inc.8$192
Biohaven Pharmaceuticals, Inc.7$149
Upsher-smith Laboratories LLC7$147
Axsome Therapeutics, Inc.6$144
Harmony Biosciences LLC5$132
Avion Pharmaceuticals5$126
Insightec,inc1$114
Supernus Pharmaceuticals, Inc.6$109
Corium, LLC5$108
SK Life Science, Inc.4$108
E.r. Squibb & Sons, L.L.C.1$107
ANI Pharmaceuticals, Inc.4$107
Merz Pharmaceuticals, LLC4$107
Alnylam Pharmaceuticals Inc.6$105
Sunovion Pharmaceuticals Inc.4$92
CSL Behring3$89
Sanofi4$86
Kyowa Kirin, Inc.5$86
GE HealthCare3$72
Averitas Pharma Inc.2$65
Johnson & Johnson4$64
Adamas Pharmaceuticals, Inc.3$51
Revance Therapeutics, Inc.2$47
Bristol Myers Squibb2$42
Scilex Pharmaceuticals Inc.2$38
Microtransponder, Inc.1$34
Arbor Pharmaceuticals, Inc.2$33
Takeda Pharmaceuticals U.S.A., Inc.1$29
Greenwich Biosciences, Inc.1$25
Azurity Pharmaceuticals, Inc.1$25
Boston Scientific1$25
Idorsia Pharmaceuticals US Inc1$23
C2n Diagnostics, LLC1$22
Genentech USA, Inc.1$16

How this compares

$66,853 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida →

Medicare billing

Part B allowed, 2024
$205,300
Medicare patients
377
Services billed
20,822

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Jacksonville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →